Eagle Asset Management Inc Pacific Biosciences Of California, Inc. Transaction History

Eagle Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$19.26 - $30.08 $11.3 Million - $17.6 Million	-585,137 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$24.86 - $35.02 $3.33 Million - $4.69 Million	-133,884 Reduced 18.62%	585,137 $15 Million
Q2 2021 Aug 11, 2021	SELL	$22.3 - $36.02 $144,013 - $232,617	-6,458 Reduced 0.89%	719,021 $25.1 Million
Q1 2021 May 14, 2021	BUY	$26.38 - $51.15 $19.1 Million - $37.1 Million	725,479 New	725,479 $24.5 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.